Adage Capital Partners
NDRM

Adage Capital Partners’s NeuroDerm Ltd. Ordinary Shares NDRM Stock Holding History

Adage Capital Partners’s Portfolio NDRM Stock Details NDRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-775,000
Closed -$23.2M – 791
2017
Q2 		$23.2M Buy
775,000
+100,000
+15% +$2.59M 0.06% 384
2017
Q1 		$17.9M Buy
675,000
+100,000
+17% +$2.48M 0.05% 425
2016
Q4 		$12.8M Buy
575,000
+298,000
+108% +$5.57M 0.03% 482
2016
Q3 		$5.12M Buy
+277,000
New +$4.8M 0.01% 610
2015
Q3 		– Sell
-750,000
Closed -$11.5M – 814
2015
Q2 		$11.5M Hold
750,000
– – 0.03% 525
2015
Q1 		$10.1M Hold
750,000
– – 0.02% 550
2014
Q4 		$10.5M Buy
+750,000
New +$5.93M 0.03% 538

Other funds holding NDRM

AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
SAM
Sandell Asset Management New York $179M AUM 65.55% 1-Year Est. Return
OP
Omni Partners London, United Kingdom $2.03B AUM 126.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
CFIC
City Financial Investment Company London, United Kingdom $562M AUM 5.93% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return
FTCM
First Trust Capital Management Chicago, Illinois $1.9B AUM 58.39% 1-Year Est. Return

Adage Capital Partners's NDRM Position: Q3 2017 in Review

Adage Capital Partners sold out of NeuroDerm Ltd. Ordinary Shares (NDRM) in Q3 2017, closing a stake of 775,000 shares — an estimated $23.2M sold.

Adage Capital Partners first reported a position in NDRM in Q4 2014 and held it in 7 quarters. The position peaked at $23.2M in Q2 2017. 81 funds tracked by Wall St. Rank hold NDRM as of Q3 2017.

  • Adage Capital Partners reported no remaining NeuroDerm Ltd. Ordinary Shares position as of Q3 2017 after selling out during the quarter.
  • Adage Capital Partners sold 775,000 NeuroDerm Ltd. Ordinary Shares shares in Q3 2017, an estimated $23.2M.
  • Adage Capital Partners first reported a position in NeuroDerm Ltd. Ordinary Shares in Q4 2014 and held it in 7 quarters.
  • Adage Capital Partners's NeuroDerm Ltd. Ordinary Shares position peaked at $23.2M in Q2 2017.
  • 81 funds tracked by Wall St. Rank held NeuroDerm Ltd. Ordinary Shares as of Q3 2017.

Based on Adage Capital Partners's 13F filing for Q3 2017, filed 14 Nov 2017.